Immunomodulating effects of egg yolk low lipid peptic digests in a murine model

Food and Agricultural Immunology

Volumn 18, Issue 1, 2007, Pages 1-15

  Nelson, Ralph ^a   Katayama, Shigeru ^b   Mine, Yoshimuri ^b   Duarte, Jairo ^a   Matar, Chantal ^a  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Egg yolk; Immune exclusion; Mucosal immunity; Primary cells culture

Indexed keywords

BACTERIA (MICROORGANISMS); MURINAE;

EID: 34147107625     PISSN: 09540105     EISSN: 14653443     Source Type: Journal    
DOI: 10.1080/09540100601178623     Document Type: Article

References (62)

1. Apter FM, Michetti P, Winner LS, Mack JA, Mekalanos JJ, Neutra MR. 1993. Analysis of the roles of antipolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun 61:5279-5285.
2. Asahi Y, Yoshikawa T, Watanabe I, Iwasaki T, Hasegawa H, Sato Y, Shimada SI, Nanno M, Matsuoka Y, Ohwaki M, et al. 2002. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J Immunol 168:2930-2938.
3. Baldwin RE. 1986. Functional properties of eggs in food. In: Stadelman WJ, Cotterill OJ, editors. Egg science and technology. Westport, CT: AVI Publishing. pp 345-351.
4. Blum S, Delneste Y, Alvareez S, Haller D, Perez PF, Bode Ch, Hammes WP, Pfeifer AMA and Schiffrin EJ. 1999. Interactions between commensal bacteria and mucosal immunocompetent cells. Int Dairy J 9:63-68.
5. Czinn SJ, Cai A, Nedrud JG. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11:637-642.
6. Galli-Stampino L, Meinjohanns E, Frische K, Meldal M, Jensen J, Werdelin O, Mouritsen S. 1997. T-cell recognition of tumor-associated carbohydrates: The nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res 15:3214-3222.
7. Gaskins HR. 1997. Imunological aspects of host/microbiota interactions at the intestinal epithelium. In: Mackie RI, Isaacson RE, editors. Gastrointestinal microbiology. New York: Chapman & Hall. pp 537-587.
8. Goodrich ME, McGee DW. 1999. Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF-β on IgA+B cells. Immunol Lett 67:11-14.
9. Husband AJ, Beagley KW, NcGhee JR. 1999. Mucosal cytokines. In: Ogra PL, McGhee JR, Bienenstock J, editors. Mucosal Immunology. New York: Academic Press. pp 541-557.
10. Jiang CM, Wang MC, Chang WH, Chang HM. 2001. Isolation of lysozyme from hen egg albumen by alcohol-insoluble cross-linked pea pod solid ion-exchange chromatography. J Sci Food Agric 66:1089-1092.
11. Jiri M, Moldoveanu Z, Elson CO. 2005. Immune response versus mucosal tolerance to mucosally admistered antigens. Vaccine 23:1800-1803.
12. Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME. 1991. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: A local defense function for IgA. Proc Nat Acad Sci USA 88:8796-8800.
13. Kaetzel CS, Robinson JK, Lamm ME. 1994. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system. J Immunol 152:72-76.
14. Kassaify ZG, Mine Y. 2004. Nonimmunized egg yolk powder can suppress the colonization of Salmonella typhimurium, Escherichia coli O157:H7, and Campylobacter jejuni in laying hens. Poultry Sci 83:1497-1506.
15. Kassaify ZG, Li EW, Mine Y. 2005. Identification of antiadhesive fraction(s) in nonimmunized egg yolk powder: In vitro study. J Agric Food Chem 53:4607-4614.
16. Kato I, Tanaka K, Yokokura T. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytes. Int J Immunopharmacol 21:121-131.
17. Kedinger M, Haffen K, Simon-Assmann P. 1987. Intestinal tissue and cell cultures. Differentiation 36:71-85.
18. Kidd P. 2003. Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8:223-246.
19. Kishimoto T, Hirano T. 1988. Molecular regulation of B lymphocyte response. Annu Rev Immunol 6:485-512.
20. Krajci P, Tasken K, Kvale D, Brandtzaeg P. 1993. Interferon-γ stimulation of messenger RNA for human secretory component (poly-Ig receptor) depends on continuous intermediate protein synthesis. Scand J Immunol 37:251-256.
21. Lamm ME, Robinson JK, Rao CK, Vaerman JP, Kaetzel CS. 1991. Epithelial transport of IgA immune complexes. Adv Exp Med Biol 310:187-191.
22. LeBlanc J, Fliss I, Matar C. 2004. Induction of a humoral response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus -fermented milk. Clin Diagn Lab Immunol 11:1171-1181.
23. LeBlanc JG, Matar C, Valdéz JC, LeBlanc J, Perdigon G. 2002. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J Dairy Sci 85:2733-2742.
24. Li-Chan E, Nakai S., Bragg DB. 1986. Lysozyme separation from egg white by cation exchange column chromatography. J Food Sci 51:1032-1036.
25. Low PL, Rutherford KJ, Gill HS, Cross ML. 2003. Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice. Int Immunopharmacol 3:393-401.
26. Mainous MR, Ertel W, Chaudry IH., Deitch EA. 1995. The gut as a cytokine-producing organ in systemic inflammation. Shock 4:193-199.
27. Matar C, Amiot J, Savoie L, Goulet J. 1996. The effect of milk fermentation by Lactobacillus helviticus on the release of peptides during in vitro digestion. J Diary Sci 79:971-979.
28. Matar C, Goulet JR, Bernier L, Brochu E. 2000. Bioactives peptides from fermented foods: Their role in the immune system. In: Fuller R, Perdigon G, editors. Probiotics 3: Immunomodulation by the gut microflora and probiotics. Norwell, Mass: Kluwer Academics Publishers. pp 193-212.
29. Matar C, Valdez JC, Medina M, Rachid M, Perdigon G. 2001. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 68:601-609.
30. Matar C, LeBlanc JG, Martin L, Perdigon G. 2003. Biologically active peptides released from fermented milk: role and functions. In: Farnworth ER, editor. Handbook of fermented functional foods. Boca Raton, FL: CRC Press. pp 177-201.
31. McCarthy KM, Young Y, Simister NE. 2000. Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: a system to study protein transport across epithelia. J Cell Sci 113:1277-1285.
32. McCartney KK, Baumgart DC, Carding SR, Brubaker JO, Offit PA. 2000. Primary murine small intestinal epithelial cells, maintained in long-term culture, are susceptible to rotavirus infection. J Virol 74:5597-5603.
33. McGhee J, Mestecky J, Dertzbaugh M, Eldridge J, Hirasawa M, Kiyono H. 1992. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 10:75-88.
34. Medici M, Vinderola CG, Perdigon G. 2004. Gut mucosal immunomodulation by probiotic fresh cheese. Int Dairy J 14:611-618.
35. Meisel H, Frister H, Schlimme E. 1989. Biologically active peptides in milk proteins. Zeitschrift fur Ernahrungswissenschaft [J Nutrition] 28:267-278.
36. Meyer TA, Noguchi Y, Ogle CK, Tiao G, Wang JJ, Fischer JE, Hasselgren PO. 1994. Endotoxin stimulates Interleukin-6 production in intestinal epithelial cells. A synergistic effect with prostaglandin E2. Arch Surg 129:1290-1295.
37. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. 1992. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 60:1786-1792.
38. Miller TL, McGee DW. 2002. Epithelial cells respond to proteolytic and non-proteolytic detachment by enhancing interleukin-6 responses. Immunology 105:101-110.
39. Moody DB, Young DC, Cheng TY, Rosat JP, Roura-Mir C, O'Connor PB, Zajonc DM, Walz A, Miller MJ, Levery SB, et al. 2004. T Cell activation by lipopeptide antigens. Science 303:527-531.
40. Moreau MC, Gaboriau-Routhiau V. 2000. Influence of resident intestinal microflora on the development and function of the intestinal-associated lymphoid tissue. In: Fuller R, Perdigon G, editors. Probiotics 3. Immunomodulation by the gut microflora and probiotics. Dordrecht, The Netherlands: Kluwer Academic Publishers. pp 69-104.
41. Mowat A, Weiner H. 1999. Oral tolerance-physiological basis and clinical applications. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunology. San Diego: Academic Press. pp 587-618.
42. Norderhaug IN, Johansen FE, Schjerven H, Brandtzaeg P. 1999. Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 19:481-508.
43. Okahashi N, Yamamoto M, Vancott JL, Chatfield SN, Roberts M, Bluethmann H, Hiroi T, Kiyono H, McGhee JR. 1996. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+/ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun 64:1516-1525.
44. Paul WE, Seder RA. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
45. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruis Holgado A. 1986. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 53:404-410.
46. Perdigon G, Alvarez S, Pesce de Ruiz Holgado A. 1991. Immunoadjuvant activity of oral Lactobacillus casei: Influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 58:485-496.
47. Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N. 1995. Immune system stimulation by probiotics. J Dairy Sci 78:1597-1606.
48. Perdigon G, Vintini E, Alvarez S, Medina M, Medini M. 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 82:1108-1114.
49. Perdigon G, Fuller R, Raya R. 2001. Lactic acid bacteria and their effect on immune system. Curr Issues Intest Microbiol 2:27-42.
50. Perdigon G, Maldonado GC, Valdez JC, Medini M. 2002. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 56(Suppl. 4):S21-26.
51. Phillips JO, Everson MP, Moldoveanu Z, Lue C, Mestecky J. 1990. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol 145:1740-1744.
52. Piskurich JF, France JA, Tamer CM, Willmer CA, Kaetzel CS, Kaetzel DM. 1993. Interferon-γ induces polymeric immunoglogulin receptor mRNA in human intestinal epithelial cells by a protein synthesis dependent mechanism. Mol Immunol 30:413-421.
53. Rodrigues M, Zerbini MC, Barbieiri D. 1998. Immunohistological study of T lymphocytes (total and helper) and B lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis. Argentinian Gastroenterol 35:223-236.
54. Rodrigues ACP, Cara CD, Fretez SHGG, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ. 2000. Saccharomyces boulardi stimulates sIgA production and the phagocytic system of gnobiotic mice. J Appl Microbiol 89:404-414.
55. Sainte-Marie G. 1962. A paraffin embedding technique for studying employing immunofluorescence. J Histochem Cytochem 10:250-256.
56. Slorach EM, Campbell FC, Dorin JR. 1999. A mouse model of intestinal stem cell function and regeneration. J Cell Sci 112:3029-3038.
57. Svanborg-Eden C, Svennerholm AM. 1978. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect Immun 2:790-797.
58. Theodore J., Standiford. 2000. Anti-inflammatory ctokines and cytokine atagonists. Curr Pharmaceut Design 6:633-649.
59. Vinderola CG, Duarte J, Thangavel D, Perdigon G, Farnworth E, Matar C. 2005a. Immunomodulating capacity of kefir. J Dairy Res 72:195-202.
60. Vinderola G, Matar C, Perdigon G. 2005b. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic: Involvement of tll-lke rceptors. Clin Diagn Lab Immunol 12:1075-1084.
61. Vintini E, Alvarez S, Medina M, Medici MV, De Budeguer M, Perdigon G. 2000. Gut mucosal immunostimulation by lactic acid bacteria. Biocell 23:223-232.
62. Williams RC, Gibbons RJ. 1972. Inhibition of bacterial adherence by secretory immunoglobulin A: A mechanism of antigen disposal. Science 177:697-699.